These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36992218)

  • 21. [Recent advances in the development of vaccines against hemorrhagic fevers caused by arenaviruses].
    Mateo M; Baize S
    Med Sci (Paris); 2023 Nov; 39(11):855-861. PubMed ID: 38018929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reverse Genetics Approaches to Control Arenavirus.
    Martínez-Sobrido L; Cheng BY; de la Torre JC
    Methods Mol Biol; 2016; 1403():313-51. PubMed ID: 27076139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.
    Mateer EJ; Maruyama J; Card GE; Paessler S; Huang C
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials.
    Olschläger S; Flatz L
    PLoS Pathog; 2013; 9(4):e1003212. PubMed ID: 23592977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease.
    Emonet SF; Seregin AV; Yun NE; Poussard AL; Walker AG; de la Torre JC; Paessler S
    J Virol; 2011 Feb; 85(4):1473-83. PubMed ID: 21123388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.
    Cheng BYH; Nogales A; de la Torre JC; Martínez-Sobrido L
    Virology; 2017 Jan; 501():35-46. PubMed ID: 27855284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Glycoprotein of the Live-Attenuated Junin Virus Vaccine Strain Induces Endoplasmic Reticulum Stress and Forms Aggregates prior to Degradation in the Lysosome.
    Manning JT; Yun NE; Seregin AV; Koma T; Sattler RA; Ezeomah C; Huang C; de la Torre JC; Paessler S
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31996435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.
    Huang C; Kolokoltsova OA; Yun NE; Seregin AV; Ronca S; Koma T; Paessler S
    J Virol; 2015 Jul; 89(14):7079-88. PubMed ID: 25926656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers.
    Fukushi S; Tani H; Yoshikawa T; Saijo M; Morikawa S
    Viruses; 2012 Oct; 4(10):2097-114. PubMed ID: 23202455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel drug discovery approaches for treating arenavirus infections.
    Pasquato A; Kunz S
    Expert Opin Drug Discov; 2016; 11(4):383-93. PubMed ID: 26882218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Junín Virus Promotes Autophagy To Facilitate the Virus Life Cycle.
    Roldán JS; Candurra NA; Colombo MI; Delgui LR
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arenavirus Quasispecies and Their Biological Implications.
    Grande-Pérez A; Martin V; Moreno H; de la Torre JC
    Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.
    Rathbun JY; Droniou ME; Damoiseaux R; Haworth KG; Henley JE; Exline CM; Choe H; Cannon PM
    J Virol; 2015 Aug; 89(16):8428-43. PubMed ID: 26041296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Arenavirus research and antiviral candidate].
    Tani H; Shuzo U
    Uirusu; 2018; 68(1):51-62. PubMed ID: 31105135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A potent Lassa virus antiviral targets an arenavirus virulence determinant.
    Madu IG; Files M; Gharaibeh DN; Moore AL; Jung KH; Gowen BB; Dai D; Jones KF; Tyavanagimatt SR; Burgeson JR; Korth MJ; Bedard KM; Iadonato SP; Amberg SM
    PLoS Pathog; 2018 Dec; 14(12):e1007439. PubMed ID: 30576397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps.
    Kerber R; Reindl S; Romanowski V; Gómez RM; Ogbaini-Emovon E; Günther S; ter Meulen J
    J Clin Virol; 2015 Mar; 64():120-7. PubMed ID: 25549822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.
    Amanat F; Duehr J; Oestereich L; Hastie KM; Ollmann Saphire E; Krammer F
    mSphere; 2018; 3(3):. PubMed ID: 29720525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease.
    Kotturi MF; Botten J; Sidney J; Bui HH; Giancola L; Maybeno M; Babin J; Oseroff C; Pasquetto V; Greenbaum JA; Peters B; Ting J; Do D; Vang L; Alexander J; Grey H; Buchmeier MJ; Sette A
    PLoS Pathog; 2009 Dec; 5(12):e1000695. PubMed ID: 20019801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Arenavirus infections].
    Tani H; Fukushi S; Yoshikawa T; Saijo M; Morikawa S
    Uirusu; 2012; 62(2):229-38. PubMed ID: 24153233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Envelope exchange for the generation of live-attenuated arenavirus vaccines.
    Bergthaler A; Gerber NU; Merkler D; Horvath E; de la Torre JC; Pinschewer DD
    PLoS Pathog; 2006 Jun; 2(6):e51. PubMed ID: 16751848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.